ReviewInternational journal of molecular sciences2020

Advances in Mast Cell Activation by IL-1 and IL-33 in Sjögren's Syndrome: Promising Inhibitory Effect of IL-37.

Pio Conti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.